Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Mesilato de deferoxamina para el tratamiento de la sobrecarga transfusional de hierro en personas con talasemia dependiente de transfusiones

Esta versión no es la más reciente

ver la versión actual 21 agosto 2013

Información

DOI:
https://doi.org/10.1002/14651858.CD004450.pub2Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 19 octubre 2005see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Fibrosis quística y enfermedades genéticas

Copyright:
  1. Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • David Roberts

    Correspondencia a: Systematic Review Initiative, NHS Blood and Transplant, Oxford, UK

    [email protected]

  • David Rees

    Department of Haematology, King's College Hospital, London, UK

  • Jo Howard

    St Thomas' Hospital, London, UK

  • Chris Hyde

    Systematic Review Initiative, NHS Blood and Transplant, Oxford, UK

  • Susan Brunskill

    Systematic Review Initiative, NHS Blood and Transplant, Oxford, UK

Contributions of authors

David Roberts: development of protocol, eligibility assessment, data extraction and analysis, quality assessment and content expert.

David Rees: development of protocol, data extraction and analysis, quality assessment and content expert.

Jo Howard: development of protocol, data extraction and analysis, quality assessment and content expert.

Chris Hyde: development of protocol, searching, data analysis and methodological expert.

Susan Brunskill: development of protocol, searching and selection of studies, eligibility assessment, data extraction and analysis, quality assessment, and methodological expert.

All authors contributed to the final report.

Sources of support

Internal sources

  • National Blood Service, Research and Development, UK.

External sources

  • No sources of support supplied

Declaraciones de interés

disponible en

Ninguno conocido.

Agradecimientos

disponible en

Se agradece a Jon Deeks su asesoramiento y comentarios sobre la sección de métodos de esta revisión.
Damos las gracias a Carol Lefebvre por proporcionar asesoramiento sobre la estrategia de búsqueda.

Se agradece a la profesora Deborah Ashby (editora estadística) y al Sr. Ashley Jones (médico estadístico) del Grupo Cochrane de Fibrosis Quística (Cochrane Cystic Fibrosis and Genetic Disorders Group), su ayuda con el contenido estadístico de esta revisión.

Version history

Published

Title

Stage

Authors

Version

2013 Aug 21

Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion‐dependent thalassaemia

Review

Sheila A Fisher, Susan J Brunskill, Carolyn Doree, Sarah Gooding, Onima Chowdhury, David J Roberts

https://doi.org/10.1002/14651858.CD004450.pub3

2005 Oct 19

Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion‐dependent thalassaemia

Review

David Roberts, David Rees, Jo Howard, Chris Hyde, Susan Brunskill

https://doi.org/10.1002/14651858.CD004450.pub2

2003 Oct 20

Desferrioxamine mesylate for managing transfusional iron overload in people with thalassaemia

Protocol

David Roberts, David Rees, Jo Howard, Chris Hyde, Simon Stanworth, Susan Brunskill

https://doi.org/10.1002/14651858.CD004450